These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15880125)
21. Histopathological changes in collagen and matrix metalloproteinase levels in articular condyle of experimental model rats with jaw deformity. Watanabe A; Yamaguchi M; Utsunomiya T; Yamamoto H; Kasai K Orthod Craniofac Res; 2008 May; 11(2):105-18. PubMed ID: 18416752 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis. Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814 [TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-7, -8, -9, -25, and -26 and CD43, -45, and -68 cell-markers in HIV-infected patients' saliva and gingival tissue. Mellanen L; Lähdevirta J; Tervahartiala T; Meurman JH; Sorsa T J Oral Pathol Med; 2006 Oct; 35(9):530-9. PubMed ID: 16968233 [TBL] [Abstract][Full Text] [Related]
24. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review. Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441 [TBL] [Abstract][Full Text] [Related]
25. The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Yamagata K; Arai C; Sasaki H; Takeuchi Y; Onizawa K; Yanagawa T; Ishibashi N; Karube R; Shinozuka K; Hasegawa Y; Chiba S; Bukawa H Bone Marrow Transplant; 2012 May; 47(5):725-30. PubMed ID: 21874059 [TBL] [Abstract][Full Text] [Related]
26. Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. Quinn B; Stone R; Uhlenhopp M; McCann S; Blijlevens N Eur J Oncol Nurs; 2007; 11 Suppl 1():S10-8. PubMed ID: 17540294 [TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients. Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198 [TBL] [Abstract][Full Text] [Related]
29. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. Andrian E; Mostefaoui Y; Rouabhia M; Grenier D J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791 [TBL] [Abstract][Full Text] [Related]
30. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Sorsa T; Gursoy UK; Nwhator S; Hernandez M; Tervahartiala T; Leppilahti J; Gursoy M; Könönen E; Emingil G; Pussinen PJ; Mäntylä P Periodontol 2000; 2016 Feb; 70(1):142-63. PubMed ID: 26662488 [TBL] [Abstract][Full Text] [Related]
31. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases. Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906 [TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Fligiel SE; Standiford T; Fligiel HM; Tashkin D; Strieter RM; Warner RL; Johnson KJ; Varani J Hum Pathol; 2006 Apr; 37(4):422-30. PubMed ID: 16564916 [TBL] [Abstract][Full Text] [Related]
39. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis. Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412 [TBL] [Abstract][Full Text] [Related]
40. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis]. Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]